Semaglutide, the active ingredient in Ozempic, and other drugs in the same class have revolutionized the treatment of obesity and type 2 diabetes. Now, a clinical trial suggests the medicines can ...

CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a randomized trial showed. In this 26-week, double-blind trial of 72 adults, 36% ...

A new study finds the use of weight loss drugs like Ozempic, Wegovy, and Zepbound in people with Type-1 Diabetes has risen sharply. It comes even though there's little information on the drugs ...

The medication labels for Ozempic and Mounjaro, which are prescribed to help people with type 2 diabetes manage blood sugar, specifically say they are not intended for use with type 1. However ...

Despite this widespread impact, many sufferers find current preventive treatments ineffective. GLP-1 diabetes drugs like Ozempic found effective against migraines Skip to main content ...

More people with type 1 diabetes are using GLP-1s like Ozempic and Zepbound, a new study found. Researchers attribute the high demand to rising rates of obesity among people with type 1 diabetes.

A box of Ozempic, a semaglutide injection drug used for treating type 2 diabetes and made by Novo Nordisk, is seen at a Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023.

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related cancers, especially colorectal cancer, according to data released on ...

But new research suggests that a special stem cell treatment may be the cure for type 1 diabetes that many have been looking for. That’s the major takeaway from the study, which was published in ...

Type 1 and type 2 diabetes are driven by very different mechanisms. In type 2 , cells in the pancreas that make insulin become less sensitive to blood sugar and produce less insulin in response.